Vasoconstrictor reaction to prostaglandins E1 and E2 in the isolated rat hindlimb mediated through serotonin release. 1993

M Smíd, and P Husek
Department of Pharmacology, Second Medical Faculty, Charles University, Prague, Czechoslovakia.

The vasoconstrictor effects of prostaglandins E (PGEs) were studied in the isolated perfused hindlimbs of the rat. Doses of PGE1 in the range of 0.01-10 micrograms caused dose-dependent increases in perfusion pressure with rapid development of tachyphylaxis. The pressure increases were inversely temperature-dependent, being 4.8 +/- 1.2 mm Hg at 37 degrees C and 22.2 +/- 1.8 mm Hg at 27 degrees C. The vasoconstriction was limited to PGE1 and PGE2. Other prostaglandins tested, PGF2 alpha, PGD2, PGA1, 7-oxo-PGI2 and arachidonic acid, were without any effect at 27 degrees C. Increased serotonin concentrations were found in the effluent after the administration of 1 microgram of PGE1. The pressor response to PGE1 was blocked by 5-HT2 antagonists, ketanserin (2 micrograms) and naftidrofuryl (100 micrograms), while the alpha-adrenoceptor antagonist phentolamine (6.7 micrograms) was without effect. Rapid tachyphylaxis of the development of vasoconstriction was observed after the repeated administration of PGE1 and PGE2. PGE1 (1 microgram) induced desensitization with more than 60 min duration. All the findings suggest that serotonin was liberated in the rat hindlimbs by PGEs.

UI MeSH Term Description Entries
D008297 Male Males
D008729 Methoxamine An alpha-1 adrenergic agonist that causes prolonged peripheral VASOCONSTRICTION. Methoxamedrin,Methoxamine Hydrochloride,Metoxamine Wellcome,Vasoxin,Vasoxine,Vasoxyl,Vasylox,Hydrochloride, Methoxamine,Wellcome, Metoxamine
D011448 Prostaglandin Antagonists Compounds that inhibit the action of prostaglandins. Prostaglandin Inhibitors,Antagonists, Prostaglandin,Inhibitors, Prostaglandin,Prostaglandin Antagonist,Prostaglandin Inhibitor,Antagonist, Prostaglandin,Inhibitor, Prostaglandin
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D006614 Hindlimb Either of two extremities of four-footed non-primate land animals. It usually consists of a FEMUR; TIBIA; and FIBULA; tarsals; METATARSALS; and TOES. (From Storer et al., General Zoology, 6th ed, p73) Hindlimbs
D000317 Adrenergic alpha-Antagonists Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. Adrenergic alpha-Receptor Blockaders,alpha-Adrenergic Blocking Agents,alpha-Adrenergic Receptor Blockaders,alpha-Blockers, Adrenergic,Adrenergic alpha-Blockers,alpha-Adrenergic Antagonists,alpha-Adrenergic Blockers,Adrenergic alpha Antagonists,Adrenergic alpha Blockers,Adrenergic alpha Receptor Blockaders,Agents, alpha-Adrenergic Blocking,Antagonists, alpha-Adrenergic,Blockaders, Adrenergic alpha-Receptor,Blockaders, alpha-Adrenergic Receptor,Blockers, alpha-Adrenergic,Blocking Agents, alpha-Adrenergic,Receptor Blockaders, alpha-Adrenergic,alpha Adrenergic Antagonists,alpha Adrenergic Blockers,alpha Adrenergic Blocking Agents,alpha Adrenergic Receptor Blockaders,alpha Blockers, Adrenergic,alpha-Antagonists, Adrenergic,alpha-Receptor Blockaders, Adrenergic
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1

Related Publications

M Smíd, and P Husek
June 1987, Naunyn-Schmiedeberg's archives of pharmacology,
M Smíd, and P Husek
December 1992, Journal of applied physiology (Bethesda, Md. : 1985),
M Smíd, and P Husek
January 1973, Advances in the biosciences,
M Smíd, and P Husek
June 1983, Prostaglandins, leukotrienes, and medicine,
M Smíd, and P Husek
August 1975, Japanese journal of pharmacology,
M Smíd, and P Husek
November 1968, British journal of pharmacology,
M Smíd, and P Husek
May 1976, Biochemical and biophysical research communications,
Copied contents to your clipboard!